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ABStrAct
This study evaluated a South African outpatient drug counselling centre’s motivational 
interviewing-based treatment programme from theory and outcomes-based perspectives. 
142 participants were interviewed at admission to the programme and followed up 6 
and 10 weeks later. Trajectories of substance use, substance dependence, self-efficacy, 
motivation (using SOCRATES sub-scales of Problem Recognition, Ambivalence and Taking 
Steps) and NA/AA affiliation were examined. Self-efficacy and SOCRATES Taking Steps 
scores increased and were significantly associated with substance use levels, which 
decreased significantly over time. Higher self–efficacy scores at end-of-treatment (6 
weeks) predicted lower substance use scores at 10 weeks. More programme attendance 
was associated with lower levels of substance use/dependence. Abstinence was achieved 
by 47% of participants.
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Global estimates suggest that approxi-
mately 5.4% of the global burden of dis-
ease is attributable to alcohol and illicit 
drug use (World Health Organization, 
2014), making substance abuse treat-
ment an urgent priority world-wide. As in 
other low- and middle-income countries 
(World Health Organization, 2010), in 
South Africa many treatment centres, es-
pecially those operating in the non-profit 
sector, operate under severe budgetary 
constraints (Myers and Parry, 2003), with 
the financial concerns of the population 
they serve typically creating significant 
barriers to treatment access (Myers et al., 
2011). 
Treatment based on motivational in-
terviewing (Miller and Rollnick 1991) has 
shown promise as a shorter, more flex-
ible treatment than traditional treatment 
programmes. Motivational interviewing 
(MI) helps people increase motivation 
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for changing substance use habits by ex-
ploring and resolving ambivalence about 
change (Lundahl and Burke, 2009). A 
feedback process using personal assess-
ment results together with pure MI is 
termed motivational enhancement thera-
py (MET) (Burke et al., 2003; Cloud et al., 
2006; Hettema, Steele, & Miller, 2005). 
MET is considered at least as effective as 
cognitive-behavioural therapy and Twelve 
Step programmes (Hettema et al., 2005), 
similar to them in terms of durability 
(Lundahl and Burke, 2009), and a cheaper 
option than other competing therapies 
due to its relative brevity (Lundahl and 
Burke, 2009). These findings, combined 
with MET’s enduring effects (Burke et al. 
2003; Lundahl et al., 2010; Lundahl and 
Burke 2009), offer good support for the 
use of MET in treatment centres. Previous 
research has focused on examining MET 
within the parameters of efficacy stud-
ies, but outcome studies of MET-based 
real-world treatment programmes under 
pragmatic conditions are rare.
The Cape Town Drug Counselling Cen-
tre offers a low-cost, outpatient treat-
ment programme with MET as its basis, 
and serves a multicultural clientele drawn 
mainly from the lower socio-economic 
areas of Cape Town and surrounds. This 
makes it an ideal setting for a pragmatic ef-
fectiveness study exploring the possibility 
of the success of MET under the usual con-
ditions of a non-profit treatment centre.
MethoD
The theory of change for the treatment 
provided by the Centre
Elaborating a theory of change for a 
programme includes mapping the desired 
responses of participants to programme 
activities, as well as the mediating pro-
cesses between programme services and 
the achievement of programme goals 
(Weis, 1998). Clients admitted to the 
Cape Town Drug Counselling Centre’s pro-
gramme are expected to attend six com-
pulsory weekly sessions each of individual 
counselling, group therapy and psycho-
educational lectures/discussions, and two 
family sessions. All are delivered using the 
key concepts of motivational interviewing 
techniques. The Centre also uses referral 
to Alcoholics Anonymous (AA) or Narcot-
ics Anonymous (NA) groups, drug testing 
and family workshops as additional treat-
ment resources. 
Increased self-efficacy and motivation 
levels were identified by staff as key me-
diating processes in order to achieve ab-
stinence. This was supported by the liter-
ature which postulates that both lead to 
positive behavioural change and resultant 
reduced substance use (Read, Kahler, & 
Stevenson, 2001). We were also interest-
ed in the relationship between levels of 
AA/NA attendance and affiliation and sub-
stance use outcomes. We hypothesized 
that self-efficacy levels, motivation lev-
els and AA/NA affiliation would increase 
over time and would be associated with 
reduced substance use and substance de-
pendence; that substance misuse would 
decrease over time; and that higher self-
efficacy levels at end-of-treatment would 
be inversely associated with substance 
use outcomes four weeks after end-of-
treatment. We further expected that pro-
gramme “dose” - the number of sessions 
clients attended – would be negatively as-
sociated with levels of substance use. 
Evaluation design
The Centre could not suspend nor-
mal operations during the evaluation, 
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eliminating the possibility of a controlled 
design. We therefore chose a theory-
based approach (Weiss, 1998), with as-
sessments at admission, immediately 
after the programme, and again at one 
month after the end of treatment, which 
allowed us to accomplish several goals: 
(1) assess whether self-efficacy, motiva-
tion and AA/NA affiliation would change 
over time and be related to outcomes, 
as predicted by the Centre’s programme 
theory (Shadish et al., 2002) ; (2) assess 
whether the desired outcomes were 
achieved; and (3) assess whether those 
outcomes, if achieved, were sustained for 
at least a month post-treatment. 
The study was approved by the Univer-
sity of Cape Town Humanities Faculty Re-
search Ethics Committee.
Measures
substance use. Substance use and 
substance dependence levels were de-
termined by the Alcohol, Smoking and 
Substance Involvement Screening Test 
(WHO ASSIST v3.0; Humeniuk et al., 
2008). Respondents were assessed for 
risk in respect of alcohol, cannabis, co-
caine, methamphetamines, inhalants, 
sedatives, hallucinogens, opiates, and 
‘other drugs’. Scores measure whether 
respondents are at low, moderate or 
high risk of experiencing problems relat-
ing to substance abuse: These risk cat-
egories are good predictors of, respec-
tively, substance use, substance abuse 
and substance dependence (Newcombe 
et al., 2005). The instrument has been 
tested for cross-cultural relevance (World 
Health Organization, 2013) and has been 
successfully utilized in a South African 
study involving substance abuse among 
South African primary care clinic patients 
(Ward et al., 2008).
variables assessing mechanisms of 
treatment
AA/NA Anonymous Affiliation Scale. 
This is a short and reliable assessment of 
participants’ levels of affiliation with AA/
NA and includes seven close-ended ques-
tions relating to number of meetings at-
tended, service at meetings, literature 
read and sponsors obtained (Humphreys 
et al., 1998). 
Socrates Stages of Change Readi-
ness and Treatment Eagerness Scale 
(SOCRATES). This is a 19-item instrument 
designed to assess levels of motivation 
for change in substance users, with three 
sub-scales - Problem Recognition, Taking 
Steps (towards change) and Ambivalence 
(Miller and Tonigan, 1996). The Recogni-
tion sub-scale assesses respondents’ self-
perceptions of drinking problems. Rec-
ognition scores are positively associated 
with problem severity, with high scores 
indicating acknowledgement of problems 
related to excessive drinking or drug use, 
while low scores reflect little or no desire 
for change. The Ambivalence sub-scale 
assesses a “weighing up” attitude towards 
change. Ambivalence scores should be 
interpreted in conjunction with Recogni-
tion scores to avoid ambiguity of results 
(Miller and Tonigan, 1996). This is ex-
emplified by a questionnaire statement, 
“I think that I am an addict”, attracting 
misleading ‘Disagree’ scores because cli-
ents expressed that they ‘knew’ that they 
were addicts - they did not merely think 
it. Therefore Ambivalence variables were 
restructured and recoded as follows: If 
the ambivalence score was equal to 1 and 
the recognition score was either 4 or 5 
then the ambivalence score was altered 
to 5. If the ambivalence score was equal 
to 2 and the recognition score was either 
4 or 5 then the ambivalence score was 
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changed to 4. The Taking Steps sub-scale 
assesses the level of action being taken 
by respondents to make positive changes 
to their drinking or drug use. High scores 
may predict successful change and taking 
active steps toward change. 
Drug-Taking Confidence Question-
naire-8 (DTCQ-8). This is an 8-item as-
sessment of levels of self-efficacy to re-
sist temptation to drink or use drugs, in 
a variety of situations. Compared against 
a 50-item drug-taking confidence ques-
tionnaire, global self-efficacy is evaluated 
with 95% accuracy, is appropriate for use 
before, throughout and after treatment, 
as well as being a particularly appropriate 
tool in telephone follow-ups (Sklar and 
Turner, 1999). 
Programme “dosage” received by each 
participant. This was obtained through 
record review, by adding the number of 
individual counselling sessions, group ses-
sions and psycho-education discussions 
attended by each participant.
Sample
The Centre operates on a rolling ad-
mission basis. A total of 261 participants 
were recruited between 24 May 2011 and 
3 April 2012, and interviewed at their as-
sessment visit after consenting to partici-
pate. Clients were followed by telephone 
immediately post-treatment (6 weeks 
from admission) and again four weeks 
later, with each follow-up having a “win-
dow period” of two weeks. As more than 
half of heroin users who relapsed after 
residential treatment did so within the 
first three days after discharge and 75% 
within one week (Gossop et al., 2002), 
and 56.5% of treatment-seekers in an out-
patient Southern California methamphet-
amine treatment study were still using at 
discharge (Rawson et al., 2005), this was 
considered an acceptable follow-up peri-
od for our study. Inclusion criteria were a 
minimum age of 18 years and active sub-
stance use or drinking during at least the 
three months before initial intake. Of the 
original 261 interviewees, 56 who did not 
begin the treatment programme were 
excluded, as were 47 who were referred 
by the Centre to in-patient facilities and 
16 others, leaving 142 participants in our 
sample. Of these, 89 were interviewed at 
all three time points, 17 at only admission 
and 6 weeks after admission, and 98 at 
admission and 10 weeks after admission.
The demographic composition of our 
in-treatment sample (N=142) was: 61% 
Coloured, 24% White, 14% Black1, 1% un-
known; 75% male, 25% female; and mean 
age 30. These characteristics did not dif-
fer significantly in any way from the group 
who only stayed for the assessment. How-
ever, individuals using heroin at high-risk 
levels (according to their baseline ASSIST 
scores) were significantly less likely to en-
ter the treatment programme than those 
not doing so (χ2 (df=1) =11.938, p=0.001). 
Conversely, individuals using metham-
phetamines at high-risk levels were sig-
nificantly more likely to enter treatment 
than those who did not (χ2 (df=1) =4.289, 
p=0.027) and methamphetamine was the 
substance most used at high-risk levels in 
the group who stayed for treatment.
Analyses
Because of an assumption that drug us-
ers who cannot be contacted on follow-up 
1 “Black”, “Coloured” and “White” are racial 
classifications used under Apartheid. While 
we reject the ideology associated with these 
pejorative terms, we note them here because 
of their continuing influence on access to 
healthcare, such as substance abuse treat-
ment centres (Myers and Parry, 2005).
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may have relapsed (Shadish et al., 2002) 
we performed an intent-to-treat analysis, 
with baseline data imputed for missing 
data on the full in-treatment sample at 
admission and 10 weeks post-admission 
(N=142). We also conducted an analy-
sis without missing data on the group of 
98 participants (69% of the sample) who 
completed questionnaires at admission 
and 10 weeks after admission, as 10-week 
data was considered a better barometer 
of success than 6-week data and our re-
sponse rate fell marginally short of the 
70% level recommended for feasibility of 
findings (Digiusto et al., 2006; Hubbard et 
al., 1997). An analysis was conducted on 
the group of 89 participants interviewed 
at all three time points to determine the 
trajectories of all variables as well as the 
impact of end-of-treatment self-efficacy 
levels on 10 weeks post-admission sub-
stance use levels. Each analysis included 
mixed effect simple regressions on every 
variable to observe independent changes 
over time as well as mixed effect multiple 
regression tests to establish the impact 
of covariates on the global ASSIST score 
in conjunction with time. Mixed effect 
multiple regression tests were run on 
a final model, including only variables 
showing significance in the previous test, 
to calculate the relative contribution of 
each independent significant variable to 
global ASSIST scores. In addition a Spear-
man correlation test was performed on 
the three-time point group to ascertain 
whether higher self-efficacy levels at end 
of treatment (6 weeks after admission) 
were associated with lower global ASSIST 
scores four weeks later. 
reSultS
The results of all three analyses are 
summarized in Table 2.
Intent-to-treat analysis (N=142): 
admission and 10 weeks post-admission
Changes occurred as expected for sub-
stance use, substance dependence and 
SOCRATES Ambivalence levels, which 
decreased significantly, while, also as ex-
pected, self-efficacy and SOCRATES Taking 
Steps levels increased significantly over 
time. There were no significant changes 
in either AA/NA affiliation or SOCRATES 
Recognition levels over time. Self-efficacy, 
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Table 1. Substance use history on admission (N=142)
Risk categories  low % Medium % High %
Methamphetamines 3 2% 34 24% 55 39%
Alcohol 54 38% 22 15% 27 19%
Cannabis 14 10% 50 35% 25 18%
Opioids 2 1% 8 6% 18 13%
Cannabis 14 10% 50 35% 25 18%
Sedatives 9 6% 32 23% 14 10%
Cocaine 8 6% 19 13% 11 8%
Other 1 1% 1 1% 2 1%
Inhalants 2 1% 2 1% 0 0%
Hallucinogens 2 1% 12 8% 0 0%
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SOCRATES Taking Steps, Ambivalence 
and dosage were all significantly nega-
tively associated with substance use over 
time, i.e., as the levels of these variables 
increased, the global ASSIST scores de-
creased. SOCRATES Recognition was 
positively associated with global ASSIST 
scores, while AA/NA Affiliation was not 
associated with any change in score. 
analysis across participants who 
provided data at admission and ten 
weeks after admission (n=98)
Results were similar in magnitude and 
direction to those found in the intent-
to-treat-analysis although differences in-
clude that SOCRATES Recognition signifi-
cantly decreased over time and SOCRATES 
Ambivalence levels did not change sig-
nificantly. The global ASSIST score and 
specific substance use scores decreased 
significantly over time while self-efficacy 
levels and SOCRATES Taking Steps levels 
increased significantly. Self-efficacy and 
SOCRATES Taking Steps were significantly 
negatively associated with the global AS-
SIST score in conjunction with time, while 
SOCRATES Recognition was significantly 
positively associated with the global AS-
SIST score. AA/NA affiliation did not indi-
vidually change in any significant way nor 
was it associated with any change in the 
global ASSIST score. The association be-
tween programme dosage and the global 
ASSIST score approached significance 
(p=0.072), with 44% of participants at-
tending at least 50% of required sessions 
and attendance figures ranging from one 
session to all possible sessions attended.
substance use levels 
At 10 weeks post-admission, 47% of 
participants reported abstinence from 
all substances while the remaining 53% 
reduced their substance use significant-
ly. Alcohol was the one exception with 
the number of participants using alcohol 
‘once or twice’ increasing by 50% (see 
Table 3) warranting further analysis: Of 
the 52 non-abstinent participants, 13 had 
used only alcohol once or twice in the fol-
low-up period (none had reported only al-
cohol use at admission), resulting in 60% 
of participants either abstinent or having 
used alcohol only once or twice. A fur-
ther 6 participants had used only alcohol 
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Table 2. Variables predicting global ASSIST scores
variable
full sample 








(10 weeks only) (10 weeks only) (6 weeks and 10 weeks)
Estimate 95% CI Estimate 95% CI Estimate 95% CI
Time (6 Weeks vs. Admission) NA NA NA NA -1.33 (-5.71 , 3.06)
Time (10 Weeks vs. Admission) -32.7*** (-40.16 , -25.24) -34.55*** (-42.8 , -26.3) 34.08*** (26.07 , 42.1)
Dosage -10.2* (-18.52 , -1.89) -7.44 (-15.56 , 0.68) -10.27*** (-15.87 , -4.67)
Self-efficacy -0.03** (-0.04 , -0.01) -0.02* (-0.04 , 0) -0.02** (-0.03 , 0)
SOCRATES Taking Steps -0.75* (-1.51 , 0) -1.37** (-2.3 , -0.45) -1.28*** (-1.94 , -0.63)
SOCRATES Recognition 1.47*** (0.86 , 2.08) 1** (0.4 , 1.6) 0.79*** (0.45 , 1.12)
SOCRATES Ambivalence -0.37*** (-0.47 , -0.27) NA NA NA NA
* p<0.05, ** p<0.01, *** p<0.001
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weekly at 10 weeks follow-up while the 
remainder of participants significantly re-
duced their substance use.
analysis across participants who provided 
data at all three time points (n=89)
Tests showed the same magnitude and 
direction as the group of 98 participants. 
Figure 1 illustrates that self-efficacy and 
SOCRATES Taking Steps scores increased 
significantly from admission to 6 weeks 
post-admission; these increased lev-
els were maintained in the month after 
treatment ended but not significantly 
further improved. Similarly, the global 
ASSIST and the substance use scores de-
creased significantly from admission to 
6 weeks post-admission and maintained 
the downward trend between 6 weeks 
and 10 weeks post-admission, but not in 
a significant way. The remaining variables 
did not change significantly at any time 
point. The unique test on this group re-
vealed that self-efficacy scores at 6 weeks 
post-admission had a significant effect on 
substance use scores at 10 weeks post-
admission. 
Figure 1. Variable trajectories over all 
three time points (n=89)
DiScuSSion
substance use outcomes 
In the group of 98 with no missing 
data our findings of 47% abstinence, a 
further 13% using alcohol only once or 
twice over the follow-up period, and sig-
nificant reduction in substance use in the 
remainder of the participants, compared 
extremely favourably to Burke and col-
leagues’ (2003) findings that 54% of par-
ticipants receiving adapted motivational 
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Table 3. Changes in substance use frequencies for all 98 Participants interviewed at 
admission and 10 weeks after admission
 using Once/Twice weekly Daily/almost Daily







Substance Ad 10 Weeks Ad 10 Weeks Ad 10 Weeks Ad 10 Weeks
Inhalants 2 0 -100% 2 0 -100% NA NA NA NA NA NA
Other 1 0 -100% NA NA NA NA NA NA 1 0 -100%
Sedatives 34 3 -91% 11 2 -82% 9 0 -100% 9 1 -89%
Opioids 18 2 -89% 2 2 0% NA NA -100% 14 0 -100%
Hallucinogens 7 1 -86% 6 1 -83% 2 0 NA NA NA NA
Cocaine 19 3 -84% 9 2 -78% 5 1 -80% 2 0 -100%
Amphetamines 55 15 -73% 10 9 -10% 12 3 -75% 26 3 -88%
Cannabis 56 18 -68% 13 9 -31% 11 4 -64% 25 5 -80%
Alcohol 68 40 -41% 16 24 50% 24 12 -50% 18 4 -78%
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interviewing interventions experienced 
overall improvement in alcohol and drug 
use. Results for heroin use should be re-
garded with some caution as although 
89% of participants reported abstinence 
from heroin use at follow-up, after- treat-
ment abstinence from heroin is consis-
tently significantly lower at up to one-
year follow-up than that of any other 
drug (Gossop et al., 2002). Similarly, the 
73% methamphetamine abstinence rate 
at follow-up compares favourably with 
outcomes of participants in an intensive 
16-week out-patient programme, where 
findings include that 58.8% of metham-
phetamine users used both drugs and 
alcohol during treatment (Rawson et al., 
2005). 
Clearly, some participants replaced 
their illicit drug-of-choice with alcohol on 
occasion. This reduced drinking pattern of 
once or twice or weekly in the follow-up 
period may fall within moderate drink-
ing limits (Whitlock et al., 2004) but not 
within the key outcome of abstinence of 
the Centre’s programme theory. 
Dosage
The significant impact of programme 
dose on the global ASSIST score, both in 
the group of 89 participants who were 
interviewed at all three time points and 
in the full in-treatment sample of 142 
participants is encouraging. This suggests 
that the more exposure clients choose to 
have to the treatment programme, the 
more their substance dependence is re-
duced, thus suggesting that it is indeed 
the treatment programme that is leading 
to reduced substance use. This is consis-
tent with findings that more time in treat-
ment is associated with better outcomes 
(Simpson et al., 1997) and that there is a 
significant positive relationship between 
higher treatment doses and better out-
comes (Burke et al. 2003).
self-Efficacy
The significant increase in self-efficacy 
scores from admission to 10 weeks post-
admission, and the significant association 
of self-efficacy scores over time with the 
reduction of global ASSIST scores, im-
ply successful application of programme 
theory. The significant association be-
tween self-efficacy levels at 6 weeks post- 
admission and 10 week post-admission 
substance use scores supports findings of 
Goldbeck and colleagues (1997) that end 
of treatment efficacy levels are predictive 
of reduced substance use levels at follow-
up, and that higher levels of abstinence 
self-efficacy are associated with better 
short-term substance abuse outcomes 
(Moos and Moos, 2007; Morgenstern et 
al., 1997). As self-efficacy levels indicate 
who will be less or more likely to experi-
ence positive outcomes after treatment 
(Ilgen et al., 2005), this questionnaire 
may be a useful tool to assess the need 
for clients to participate in the Centre’s 
aftercare programme.
sOCRaTEs subscales 
The significant positive relationship 
between SOCRATES Recognition scores 
and global ASSIST scores is in keeping 
with Miller and Tonigan’s (1996) asser-
tions that higher levels of recognition of 
a drinking or drug problem imply greater 
problem severity and vice versa. This re-
lationship remained stable over time, 
indicating that the recognition sub-scale 
could be a useful additional treatment 
tool for counsellors to determine and ad-
dress problem severity. The significant in-
crease in the SOCRATES Taking Steps score 
implies again the successful application of 
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programme theory, in keeping with Miller 
and Tonigan’s (1996) findings that high 
scores on this subscale are associated 
with successful change, offering counsel-
lors the opportunity to gauge motivation 
levels of clients before and during their 
treatment process. A possible explana-
tion for the inconsistent results of the 
ambivalence variable between analyses is 
that ambivalence is a constantly fluctuat-
ing state (Cloud et al., 2006) and conse-
quently is not expected to follow a linear 
path to resolution. It is also possible that 
the ambiguity of the ambivalence-related 
questions, as acknowledged by Miller and 
Tonigan (1996), and the restructure of the 
ambivalence variable did not accurately 
reflect levels of ambivalence.
Na/aa affiliation
Although most subjects drop out of, 
or sporadically attend, Twelve Step pro-
grammes after end-of-treatment (Cloud 
et al., 2006), our findings showed no sig-
nificant change in NA/AA affiliation even 
during the treatment period. As Twelve 
Step programmes are affordable and ef-
fective post–treatment support options 
(Read et al., 2001) and attending Twelve 
Step self-help groups improves post-
treatment outcomes as well as reduces 
the cost of continuing care to govern-
ment (Humphreys and Moos, 2007), it is 
extremely important that this Centre’s cli-
ents be introduced to the benefits of NA/
AA affiliation before end of treatment. 
We therefore recommend that referral 
procedures to AA/NA be revised: A direc-
tive strategy, where therapists actively 
followed up clients’ engagement with AA 
during treatment (Walitzer et al., 2009), 
and an ‘intensive referral’ approach, in 
which both client and counsellor were 
actively involved in initiating contact with 
Twelve Step self-help groups (Timko et al., 
2006), were both found to result in signifi-
cantly more Twelve Step involvement and 
more improvement in alcohol and drug 
use after treatment than the treatment-
as-usual condition. 
As causal relations cannot be firmly in-
ferred by data from a non-experimental 
study our findings remain tentative, and it 
is of course possible that it was the more 
motivated clients who were successful 
and completed treatment. Although reli-
ance on self-report from participants is 
a methodological vulnerability, partici-
pants’ self-reported substance use has 
been found to be consistent with the re-
sults of urine drug screens (Project MATCH 
Research Group, 1997a). The short dura-
tion of follow-up is also a limitation of 
this study as it is possible that findings 
may have differed after a longer period 
of time had elapsed. Although NA/AA af-
filiation did not increase as expected, this 
shortcoming increased confidence that 
changes found were due to the treatment 
programme rather than any other com-
peting recovery mechanism. Possibilities 
for future research include investigating 
methods to optimize AA/NA attendance, 
particularly in poorly resourced commu-
nities, through the treatment community 
and beyond. Future studies should also 
include a control group, and follow par-
ticipants over a longer period.
Despite these limitations this study 
provides good evidence of significant out-
comes in the reduction of substance use 
and substance dependence and in the 
increase of motivational and self-efficacy 
levels. Findings support programme and 
motivational interviewing theory, which 
both postulate high levels of self-efficacy 
and motivation as beneficially impact-
ing on substance use and substance 
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dependence, offering further evidence 
of programme efficacy. All of these pro-
gramme effects are particularly encour-
aging in the context of the relative cost-
effectiveness and short duration of the 
treatment programme. 
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